User login
Continuing the important dialogue regarding the use of fecal microbiota transplants (FMT) to treat recurrent C. difficile infection, your colleague, Colleen Kelly, M.D., published a blog in Huffington Post highlighting this life-saving procedure.
In the blog post, Dr. Kelly, AGA expert spokesperson on FMT and clinical assistant professor of medicine at Women’s Medicine Collaborative, Warren Alpert Medical School of Brown University, discusses her experience providing more than 100 FMTs over the past 5 years.
Dr. Kelly also discusses the regulatory challenges she faced in establishing her ongoing NIH-funded, randomized, placebo-controlled clinical trial of FMT for recurrent C. difficile infections.
Read Dr. Kelly’s blog post to learn more about her experience with FMT, regulatory pushback she has encountered, and her thoughts on FDA involvement at http://ow.ly/mQevL.
Continuing the important dialogue regarding the use of fecal microbiota transplants (FMT) to treat recurrent C. difficile infection, your colleague, Colleen Kelly, M.D., published a blog in Huffington Post highlighting this life-saving procedure.
In the blog post, Dr. Kelly, AGA expert spokesperson on FMT and clinical assistant professor of medicine at Women’s Medicine Collaborative, Warren Alpert Medical School of Brown University, discusses her experience providing more than 100 FMTs over the past 5 years.
Dr. Kelly also discusses the regulatory challenges she faced in establishing her ongoing NIH-funded, randomized, placebo-controlled clinical trial of FMT for recurrent C. difficile infections.
Read Dr. Kelly’s blog post to learn more about her experience with FMT, regulatory pushback she has encountered, and her thoughts on FDA involvement at http://ow.ly/mQevL.
Continuing the important dialogue regarding the use of fecal microbiota transplants (FMT) to treat recurrent C. difficile infection, your colleague, Colleen Kelly, M.D., published a blog in Huffington Post highlighting this life-saving procedure.
In the blog post, Dr. Kelly, AGA expert spokesperson on FMT and clinical assistant professor of medicine at Women’s Medicine Collaborative, Warren Alpert Medical School of Brown University, discusses her experience providing more than 100 FMTs over the past 5 years.
Dr. Kelly also discusses the regulatory challenges she faced in establishing her ongoing NIH-funded, randomized, placebo-controlled clinical trial of FMT for recurrent C. difficile infections.
Read Dr. Kelly’s blog post to learn more about her experience with FMT, regulatory pushback she has encountered, and her thoughts on FDA involvement at http://ow.ly/mQevL.